Liability, awards and settlements

10.8, cancer drug pricing, settlement

US: the Connecticut Attorney General announced that GlaxoSmithKline Plc has agreed to a US$70mn settlement over cancer drug prices. Attorney General Richard Blumenthal said in a statement the settlement will provide restitution to consumers in Connecticut, New York, Nevada, Montana and Arizona who suffered from a “decade long company scheme to inflate the price of two cancer drugs [Zofran and Kytril]”.